Home › Trial NCT02576431
A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
- Trial IDNCT02576431
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorBayer
- Enrollment215
- Start date2015-09-30
- ConditionsSolid Tumors Harboring NTRK Fusion
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.